139 related articles for article (PubMed ID: 35537928)
1. Passion, pressure and pragmatism: how fertility clinic medical directors view IVF add-ons.
Iacoponi O; van de Wiel L; Wilkinson J; Harper JC
Reprod Biomed Online; 2022 Jul; 45(1):169-179. PubMed ID: 35537928
[TBL] [Abstract][Full Text] [Related]
2. The prevalence, promotion and pricing of three IVF add-ons on fertility clinic websites.
van de Wiel L; Wilkinson J; Athanasiou P; Harper J
Reprod Biomed Online; 2020 Nov; 41(5):801-806. PubMed ID: 32888824
[TBL] [Abstract][Full Text] [Related]
3. VALUE study: a protocol for a qualitative semi-structured interview study of IVF add-ons use by patients, clinicians and embryologists in the UK and Australia.
Armstrong SC; Lensen S; Vaughan E; Wainwright E; Peate M; Balen AH; Farquhar CM; Pacey A
BMJ Open; 2021 May; 11(5):e047307. PubMed ID: 34020980
[TBL] [Abstract][Full Text] [Related]
4. Is the use of IVF add-on treatments driven by patients or clinics? Findings from a UK patient survey.
Cirkovic S; Wilkinson J; Lensen S; Jackson E; Harper J; Lindemann K; Costa-Font J
Hum Fertil (Camb); 2023 Dec; 26(2):365-372. PubMed ID: 37063051
[TBL] [Abstract][Full Text] [Related]
5. How common is add-on use and how do patients decide whether to use them? A national survey of IVF patients.
Lensen S; Hammarberg K; Polyakov A; Wilkinson J; Whyte S; Peate M; Hickey M
Hum Reprod; 2021 Jun; 36(7):1854-1861. PubMed ID: 33942073
[TBL] [Abstract][Full Text] [Related]
6. The crafting of hope: Contextualising add-ons in the treatment trajectories of IVF patients.
Perrotta M; Hamper J
Soc Sci Med; 2021 Oct; 287():114317. PubMed ID: 34492406
[TBL] [Abstract][Full Text] [Related]
7. Ethics and IVF add-ons: We need to talk about it.
Braga DPAF; Setti AS; Borges E
JBRA Assist Reprod; 2022 Aug; 26(3):371-373. PubMed ID: 35930629
[TBL] [Abstract][Full Text] [Related]
8. "Add-Ons" for Assisted Reproductive Technology: Do Patients Get Honest Information from Fertility Clinics' Websites?
Galiano V; Orvieto R; Machtinger R; Nahum R; Garzia E; Sulpizio P; Marconi AM; Seidman D
Reprod Sci; 2021 Dec; 28(12):3466-3472. PubMed ID: 33939166
[TBL] [Abstract][Full Text] [Related]
9. IVF add-ons in Australia and New Zealand: A systematic assessment of IVF clinic websites.
Lensen S; Chen S; Goodman L; Rombauts L; Farquhar C; Hammarberg K
Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):430-438. PubMed ID: 33594674
[TBL] [Abstract][Full Text] [Related]
10. Patient and professional perspectives about using in vitro fertilisation add-ons in the UK and Australia: a qualitative study.
Armstrong SC; Vaughan E; Lensen S; Caughey L; Farquhar CM; Pacey A; Balen AH; Peate M; Wainwright E
BMJ Open; 2023 Jul; 13(7):e069146. PubMed ID: 37495387
[TBL] [Abstract][Full Text] [Related]
11. Analysis of fertility clinic marketing of complementary therapy add-ons.
Stein J; Harper JC
Reprod Biomed Soc Online; 2021 Aug; 13():24-36. PubMed ID: 34141907
[TBL] [Abstract][Full Text] [Related]
12. Patient informed choice in the age of evidence-based medicine: IVF patients' approaches to biomedical evidence and fertility treatment add-ons.
Perrotta M; Hamper J
Sociol Health Illn; 2023 Feb; 45(2):225-241. PubMed ID: 36369731
[TBL] [Abstract][Full Text] [Related]
13. Do à la carte menus serve infertility patients? The ethics and regulation of in vitro fertility add-ons.
Wilkinson J; Malpas P; Hammarberg K; Mahoney Tsigdinos P; Lensen S; Jackson E; Harper J; Mol BW
Fertil Steril; 2019 Dec; 112(6):973-977. PubMed ID: 31703942
[TBL] [Abstract][Full Text] [Related]
14. A Focus on Maternal Health Before Assisted Reproduction: Results From a Pilot Survey of Canadian IVF Medical Directors.
Dayan N; Spitzer K; Laskin CA
J Obstet Gynaecol Can; 2015 Jul; 37(7):648-655. PubMed ID: 26366823
[TBL] [Abstract][Full Text] [Related]
15. Moral justification for the use of 'add-ons' in assisted reproductive technology: experts' views and experiences.
Gallagher S; Kerridge I; Newson A; Attinger S; Norman RJ; Lipworth W
Reprod Biomed Online; 2024 Feb; 48(2):103637. PubMed ID: 38185024
[TBL] [Abstract][Full Text] [Related]
16. Is it ethical to provide IVF add-ons when there is no evidence of a benefit if the patient requests it?
Zemyarska MS
J Med Ethics; 2019 May; 45(5):346-350. PubMed ID: 30745435
[TBL] [Abstract][Full Text] [Related]
17. Talking about possible IVF/ICSI failure and need for multiple cycles in treatment planning: qualitative investigation of multi-cycle planning and its acceptability to patients and staff.
Harrison C; Boivin J; Gameiro S
Hum Reprod; 2022 Mar; 37(3):488-498. PubMed ID: 35040994
[TBL] [Abstract][Full Text] [Related]
18. "It all depends on why it's red": qualitative interviews exploring patient and professional views of a traffic light system for IVF add-ons.
Lensen S; Armstrong S; Vaughan E; Caughey L; Peate M; Farquhar C; Pacey A; Balen AH; Wainwright E
Reprod Fertil; 2023 May; 4(2):. PubMed ID: 37140974
[TBL] [Abstract][Full Text] [Related]
19. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
Santiago-Delefosse M; Cahen F; Coeffin-Driol C
Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
[TBL] [Abstract][Full Text] [Related]
20. Clinical adjuncts in in vitro fertilization: a growing list.
Kamath MS; Mascarenhas M; Franik S; Liu E; Sunkara SK
Fertil Steril; 2019 Dec; 112(6):978-986. PubMed ID: 31703943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
